Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 6 Propensity-matched comparison outcomes in patients who did or did not receive HES before or after cardiopulmonary bypass

From: Large volume infusions of hydroxyethyl starch during cardiothoracic surgery may be associated with postoperative kidney injury: propensity-matched analysis

  HES (n = 481) Control (n = 962) p value
AKI incidents 128 (26.6%) 259 (26.9%) 0.95
AKI stage
 1 81 (16.8%) 162 (16.8%)  
 2 17 (3.5%) 42 (4.4%)  
 3 30 (6.2%) 55 (5.7%)  
Peak creatinine (mg/dL) 0.94 (0.76–1.26) 0.95 (0.74–1.35) 0.878
Need for RRT 24 (5.0%) 43 (4.5%) 0.757
ICU length of stay (days) 3 (3–5) 3 (3–4) 0.0301
28-day hospital free days (days) 11 (5–14) 12 (5–15) 0.293
Hospital mortality 16 (3.3%) 27 (2.8%) 0.702
  1. Data are expressed as medians with 25th to 75th percentiles or percentages
  2. HES hydroxyethyl starch, AKI acute kidney injury, RRT renal replacement therapy, ICU intensive care unit